Bicara Therapeutics shows deep and permanent responses with Ficerafusp alfa Plus Pembrolizumab in 1L HPV R/M HNSCC in ASCO 2025

Photo of author

By [email protected]




Bicara Therapeutics shows deep and permanent responses with Ficerafusp alfa Plus Pembrolizumab in 1L HPV R/M HNSCC in ASCO 2025



[og_img]

Source link

Leave a Comment